Samlyn Capital’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-61,926
Closed -$53.7M 117
2022
Q3
$53.7M Sell
61,926
-38,154
-38% -$23.9M 1% 32
2022
Q2
$43.8M Buy
100,080
+41,585
+71% +$21.7M 0.88% 34
2022
Q1
$37.1M Buy
58,495
+8,613
+17% +$5.43M 0.53% 54
2021
Q4
$44.4M Buy
49,882
+38,249
+329% +$40.2M 0.61% 46
2021
Q3
$14.8M Buy
11,633
+3,416
+42% +$4.14M 0.2% 91
2021
Q2
$9.94M Buy
+8,217
New +$11.1M 0.15% 83

Other funds holding CANO

Samlyn Capital's CANO Position: Q4 2022 in Review

Samlyn Capital sold out of Cano Health, Inc. (CANO) in Q4 2022, closing a stake of 61,926 shares — an estimated $53.7M sold.

Samlyn Capital first reported a position in CANO in Q2 2021 and held it in 6 quarters. The position peaked at $53.7M in Q3 2022. 186 funds tracked by Wall St. Rank hold CANO as of Q4 2022.

  • Samlyn Capital reported no remaining Cano Health, Inc. position as of Q4 2022 after selling out during the quarter.
  • Samlyn Capital sold 61,926 Cano Health, Inc. shares in Q4 2022, an estimated $53.7M.
  • Samlyn Capital first reported a position in Cano Health, Inc. in Q2 2021 and held it in 6 quarters.
  • Samlyn Capital's Cano Health, Inc. position peaked at $53.7M in Q3 2022.
  • 186 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2022.

Based on Samlyn Capital's 13F filing for Q4 2022, filed 14 Feb 2023.